» Articles » PMID: 29345968

Mature Gastric Chief Cells Are Not Required for the Development of Metaplasia

Abstract

During human gastric carcinogenesis, intestinal metaplasia is frequently seen in the atrophic stomach. In mice, a distinct type of metaplasia known as spasmolytic polypeptide-expressing metaplasia (SPEM) is found in several inflammatory and genetically engineered models. Given the diversity of long- and short-term models of mouse SPEM, it remains unclear whether all models have a shared or distinct molecular mechanism. The origin of SPEM in mice is presently under debate. It is postulated that stem or progenitor cells acquire genetic alterations that then supply metaplastic cell clones, whereas the possibility of transdifferentiation or dedifferentiation from mature gastric chief cells has also been suggested. In this study, we report that loss of chief cells was sufficient to induce short-term regenerative SPEM-like lesions that originated from chief cell precursors in the gastric neck region. Furthermore, Lgr5 mature chief cells failed to contribute to both short- and long-term metaplasia, whereas isthmus stem and progenitor cells efficiently contributed to long-term metaplasia. Interestingly, multiple administrations of high-dose pulsed tamoxifen induced expansion of Lgr5 expression and Lgr5-CreERT recombination within the isthmus progenitors apart from basal chief cells. Thus we conclude that short-term SPEM represents a regenerative process arising from neck progenitors following chief cell loss, whereas true long-term SPEM originates from isthmus progenitors. Mature gastric chief cells may be dispensable for SPEM development. NEW & NOTEWORTHY Recently, dedifferentiation ability in gastric chief cells during metaplasia development has been proposed. Our findings reveal that lesions that were thought to be acute metaplasia in fact represent normal regeneration supplied from neck lineage and that isthmus stem/progenitors are more responsible for sustained metaplastic changes. Cellular plasticity in gastric chief cells may be more limited than recently highlighted.

Citing Articles

H. Pylori-Facilitated TERT/Wnt/β-Catenin Triggers Spasmolytic Polypeptide-Expressing Metaplasia and Oxyntic Atrophy.

He L, Zhang X, Zhang S, Wang Y, Hu W, Li J Adv Sci (Weinh). 2024; 12(3):e2401227.

PMID: 39587848 PMC: 11744579. DOI: 10.1002/advs.202401227.


The role of gastric mucins and mucin-related glycans in gastric cancers.

Arai J, Hayakawa Y, Tateno H, Fujiwara H, Kasuga M, Fujishiro M Cancer Sci. 2024; 115(9):2853-2861.

PMID: 39031976 PMC: 11463072. DOI: 10.1111/cas.16282.


Revolutionizing Gastric Cancer Prevention: Novel Insights on Gastric Mucosal Inflammation-Cancer Transformation and Chinese Medicine.

Liu L, Fan X, Tang X Chin J Integr Med. 2024; .

PMID: 38676828 DOI: 10.1007/s11655-024-3806-5.


Role and research progress of spasmolytic polypeptide‑expressing metaplasia in gastric cancer (Review).

Chong Y, Yu D, Lu Z, Nie F Int J Oncol. 2024; 64(3).

PMID: 38299264 PMC: 10836494. DOI: 10.3892/ijo.2024.5621.


Gastric Stem Cell Biology and Helicobacter pylori Infection.

Wizenty J, Sigal M Curr Top Microbiol Immunol. 2024; 444:1-24.

PMID: 38231213 DOI: 10.1007/978-3-031-47331-9_1.


References
1.
Wang T, Dangler C, Chen D, Goldenring J, Koh T, Raychowdhury R . Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 1999; 118(1):36-47. DOI: 10.1016/s0016-5085(00)70412-4. View

2.
Goldenring J, Ray G, Coffey R, Meunier P, Haley P, Barnes T . Reversible drug-induced oxyntic atrophy in rats. Gastroenterology. 2000; 118(6):1080-93. DOI: 10.1016/s0016-5085(00)70361-1. View

3.
Correa P . Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52(24):6735-40. View

4.
Nomura S, Yamaguchi H, Ogawa M, Wang T, Lee J, Goldenring J . Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2005; 288(2):G362-75. DOI: 10.1152/ajpgi.00160.2004. View

5.
Lee C, Rickman B, Rogers A, Ge Z, Wang T, Fox J . Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 2008; 68(9):3540-8. PMC: 2653414. DOI: 10.1158/0008-5472.CAN-07-6786. View